GoKawiilAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug collaboration
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics as part of an expanded partnership to develop cancer treatments. Summit's shares jumped in after-hours trading following the announcement.